COHERUS ONCOLOGY INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.83
-7.60%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-28.4%
3 months
-42.4%
6 months
-53.9%
1 year
-51.2%
Year to date
-41.5%
52-week range
$0.83 – $2.51
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$128.2M
P/E
-1
P/B
2.1
P/S
2.5
Revenue
$50.94M
Net income
-$132.13M
Diluted EPS
-1.06
Gross margin
68.90%
Net margin
-259.40%
Return on equity
-183.40%
Total debt
$37.25M
Cash
$82.92M
Free cash flow
-$186.03M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $14.31M | -$20.63M | 70.40% | -144.20% | -$62.09M |
| Mar 31, 2026 | $12.31M | -$38.33M | 69.00% | -311.30% | -$57.89M |
| Dec 31, 2025 | $12.75M | -$37.64M | 68.30% | -295.30% | -$19.72M |
| Sep 30, 2025 | $11.57M | -$35.53M | 67.80% | -307.10% | -$46.34M |
| Jun 30, 2025 | $10.25M | $297.77M | 66.90% | 2903.90% | -$46.63M |
| Mar 31, 2025 | $7.6M | -$56.57M | 65.10% | -744.40% | -$25.83M |
| Dec 31, 2024 | $54.14M | -$50.7M | 37.50% | -93.60% | $28.61M |
| Sep 30, 2024 | $70.77M | -$10.75M | 70.70% | -15.20% | -$62.02M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CHRS news
All market newsNo ticker-linked stories are in the current archive.